Trademark: OBODENCE 2427899
Word
OBODENCE
ID
2427899
Trademark Type
WORD
Status
Protected: Registered/protected
Application Date
05 January 2024
Registration Date
05 January 2024
Renewal Date
05 January 2034
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceuticals; medicines for human purposes; pharmaceutical preparations; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculo-skeletal disorders; biological preparations for medical purposes; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer, tumour diseases and multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer.
Pharmaceuticals; medicines for human purposes; pharmaceutical preparations; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculo-skeletal disorders; biological preparations for medical purposes; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer, tumour diseases and multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer.